ASP Isotopes CFO Heather Kiessling Reports Sale of Common Shares

ASP Isotopes Inc. Held Annual Shareholder Meeting

Renergen, ASP Isotopes' Scheme of Arrangement Now Unconditional

ASP Isotopes Secures Regulatory Approvals for Renergen Acquisition

ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquisition of Renergen Limited

Interim CEO and COO Robert Ainscow Reports Sale of ASP Isotopes Inc. Common Shares

Paul Mann Returns as CEO of ASP Isotopes Inc

ASP Isotopes Initiated at Overweight by Cantor Fitzgerald

Cantor Fitzgerald Initiates Coverage on ASP Isotopes With Outperform Rating, $13 Price Target

ASP Isotopes CEO Paul Mann to Return From Medical Leave

Jse: Iso - Aspi Announces Paul Mann to Return From Temporary Leave of Absence as Executive Chairman and Chief Executive Officer

ASP Isotopes Inc - Paul Mann to Resume Full CEO Duties January 19, 2026

Press Release: ASP Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Executive Chairman and Chief Executive Officer

Jse: Iso - Distribution of Form of Proxy to Stockholders on the South African (Jse) Register

ASP Isotopes Inc. Files Initial Statement of Beneficial Ownership for EVP, General Counsel, and Secretary Donald George Ainscow

Executive Officer Paul Elliot Mann Reports Sale of ASP Isotopes Inc. Common Shares

BRIEF-Asp Isotopes Inc - On Nov 27, Extended Date For Renergen Acquisition Offer Conditions - SEC Filing

BUZZ-ASP Isotopes rises after backing research at Wits University

ASP Isotopes Announces Endowment of New Photonics Chair at Wits University to Advance Photonics Research